>90% of Multiplex Publications with 20+ IHC markers use Imaging Mass Cytometry
The first time I learned this figure I frankly did not believe it (check it out for yourself). I asked, "How could this [...]
Imaging Mass Cytometry Overview Video
Curious to learn more about Visikol's Imaging Mass Cytometry services? Watch the video below for a brief overview! [...]
How to Use Our Multiplex Project Designer
Here at Visikol, we specialize in a diverse range of scientific applications, though our focus can be broken down [...]
The Value of Using IMC
Lung cancer has predominated as one of the leading causes of death worldwide, with lung cancer patients facing a [...]
Visikol – The Leading Provider of Multiplex Tissue Imaging Services
Visikol started providing researchers with advanced tissue imaging services over six years ago and over this period of time [...]
Standard BioTools Announces Collaboration Agreement With Visikol to Offer Multiplex Imaging Mass Cytometry Services
SOUTH SAN FRANCISCO, Calif., October 11, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose [...]
Download Our New Multiplex Tissue Imaging eBook
Download our Multiplex Tissue Imaging eBook Today! With the recent advances in the field of tumor immunology and cancer immunotherapy, [...]
When to Use IMC Over Multiplex Fluorescence
Human breast cancer tissue showing pan-keratin (lime), E-cadherin (red), collagen 1 (cyan), DNA2 (blue) As a company [...]
Visikol Partners with Fluidigm to offer its Clients Imaging Mass Cytometry Services
Visikol originally began a little over four years ago focused entirely on providing researchers with reagents to image tissues [...]
Visikol Launches Imaging Mass Cytometry Services
Hampton, NJ --- As a leader in advanced tissue imaging and digital pathology services, Visikol is excited to announce [...]